The International Society of Nephrology (ISN)

The International Society of Nephrology (ISN) The International Society of Nephrology is a global professional association dedicated to advancing worldwide kidney health. www.theisn.org
(1)

The International Society of Nephrology (ISN) is advancing kidney care worldwide. Through our scientific and capacity-building activities in advocacy, education and research, we bridge gaps in global kidney care, engaging in a collaborative effort to improve kidney disease prevention, diagnosis and treatment. With over 10,000 professional members from over 150 countries, the ISN represents a wide international network and an efficient platform for timely scientific exchange, debate and communication between healthcare professionals involved in preventing and treating kidney disease. By collaborating with more than 100 national and regional societies, we reach out to an additional 30,000 health professionals globally. Our overarching purpose is to tackle the global burden of acute kidney injury (AKI), chronic kidney disease (CKD) and end-stage kidney disease (ESKD), improving patient care through an interconnected advocacy, education and research strategy.

ISN is proud to recognize 4 centers in the Oceania and South-East Asia (OSEA) region that have earned ISN Regional Train...
22/01/2026

ISN is proud to recognize 4 centers in the Oceania and South-East Asia (OSEA) region that have earned ISN Regional Training Centers status: Mahidol University (Thailand), National Kidney and Transplant Institute (Philippines), Hospital Tuanku Ja’afar Seremban (Malaysia), and Colonial War Memorial Hospital (Fiji). These centers will serve as regional hubs for training, mentorship, collaboration, strengthening local capacity and advancing high-quality kidney care for patients across the region.

Read more and explore the 37 global ISN Regional Training Centers ➡️ http://lite.spr.ly/6003ON1z

– Advancing kidney health worldwide. Together.

22/01/2026

𝗜𝗦𝗡 𝗩𝗜𝗗𝗘𝗢 𝗔𝗕𝗦𝗧𝗥𝗔𝗖𝗧 𝗦𝗘𝗥𝗜𝗘𝗦: Randomized, Double-Blind, Placebo-Controlled Phase 2a Study Assessing the Efficacy and Safety of Felzartamab for IgA Nephropathy. 2025 from Kidney International https://www.kidney-international.org/article/S0085-2538(25)00488-0/fulltext

by Kajaree Giri & Dilushi Wijayaratne

⚠ Kidney International's February issue is out! Read the latest news in research, highlights from current literature, co...
21/01/2026

⚠ Kidney International's February issue is out! Read the latest news in research, highlights from current literature, comprehensive reviews, and in-depth case studies.
Read the editor's pick for this month:
➡️ ICD-10 Codes for APOL1-Mediated Kidney Disease http://lite.spr.ly/6002O4nM
➡️ Bridging global kidney care gap through data: Introducing the International Society of Nephrology–Global Kidney Health Atlas (ISN-GKHA) Interactive Map http://lite.spr.ly/6004O4nO
➡️ Empowering the next generation for kidney health advancement worldwide: The Young Nephrologists Committee of the International Society of Nephrology http://lite.spr.ly/6006O4nu
➡️ Establishing a core outcome measure for life participation in children with chronic kidney disease: a Standardised Outcomes in Nephrology – (SONG-Kids) consensus workshops report http://lite.spr.ly/6008O4nr
➡️ Equity in evidence: Overcoming barriers to kidney trials in low resource settings http://lite.spr.ly/6000O4np
➡️ A randomized controlled trial evaluated the effect of pravastatin on kidney disease outcomes in adult patients with early-stage autosomal dominant polycystic kidney disease http://lite.spr.ly/6002O4nn
Grow professionally with the ISN. Access high-impact scientific and clinical research through our journals. Join/renew your ISN Membership ➡️ http://lite.spr.ly/6004O4nk
- Advancing kidney health worldwide. Together.

🤝 Strengthening global action on diabetes-related kidney diseaseThe International Society of Nephrology (ISN) and the In...
21/01/2026

🤝 Strengthening global action on diabetes-related kidney disease

The International Society of Nephrology (ISN) and the International Diabetes Federation have signed a Memorandum of Understanding (MoU), marking an important step toward closer collaboration between the kidney and diabetes communities.

Diabetes is the leading cause of chronic kidney disease worldwide. With over 850 million people living with CKD and 590 million with diabetes, coordinated action has never been more urgent.

Through this partnership, ISN and IDF will work together on:
🔹 Joint advocacy aligned with global priorities such as SDG 3.4, SDG 3.8, and the WHO Global Diabetes Compact
🔹 Education, capacity building, and scientific exchange
🔹 Coordinated awareness initiatives around World Kidney Day and World Diabetes Day

This MoU reinforces ISN’s commitment to strategic partnerships that elevate kidney health within the broader NCD agenda and advance equitable access to prevention and care worldwide.

Since its launch in 2016 to address a critical gap in nephrology publishing, Kidney International Reports® (KIR) has gro...
21/01/2026

Since its launch in 2016 to address a critical gap in nephrology publishing, Kidney International Reports® (KIR) has grown into a leading fully open-access journal for clinical and translational kidney research. As we mark this milestone, we look ahead to the next decades of innovation, inclusivity, and impact in nephrology publishing, to reaffirm KIR’s commitment to disseminating high-quality kidney science worldwide and advancing kidney health for all. 🔗 http://lite.spr.ly/6008O2vG

𝗧𝗢𝗗𝗔𝗬: ISN North and East Asia Regional Board Webinar: "Transforming CKD Care: Integrating SGLT2 Inhibitors, nsMRAs, and...
20/01/2026

𝗧𝗢𝗗𝗔𝗬: ISN North and East Asia Regional Board Webinar: "Transforming CKD Care: Integrating SGLT2 Inhibitors, nsMRAs, and GLP1Ras."
🗣️ Sydney Tang
👤 Hyeong Cheon Park
🗓️ January 20
🕓 8 am CET
🔗 Free registration: http://lite.spr.ly/60023eqE

The 2025 UN Political Declaration on NCDs is a major global commitment.How do we turn it into real change for people liv...
19/01/2026

The 2025 UN Political Declaration on NCDs is a major global commitment.
How do we turn it into real change for people living with circulatory conditions?
On February 24, the Global Coalition for Circulatory Health brings together policymakers, clinicians, and patient advocates to unpack what the Declaration actually means for cardiovascular disease, diabetes, and kidney disease, and what must happen next at country level.
Join us to explore how integrated, people-centred primary care can translate global commitments into action.
🗓️ February 24
🕓 3 pm CET
🔗 Free registration: http://lite.spr.ly/6009OxRb Multilingual subtitles

The ISN Academy Genetics Curriculum is now live, helping nephrologists use genetic testing to diagnose earlier, personal...
16/01/2026

The ISN Academy Genetics Curriculum is now live, helping nephrologists use genetic testing to diagnose earlier, personalize treatment, and improve patient outcomes. 11 expert-led recorded lectures with roundtable discussions with global specialists, providing clear, real-world explanations of genetic principles and their clinical applications.

Current topics include:
• Genetics for the nephrologist
• Clinical utility of genetic testing in nephrology
• Genetic basis of polycystic kidney disease and therapeutic options
• Genetics of Alport syndrome
• Complement-mediated kidney diseases

🎧 Plus, the first roundtable discussion is available as an ISN podcast.

Explore ISN Academy Genetics Curriculum ➡️ http://lite.spr.ly/6003OxG9

📖 This weekend don't miss our Kidney International Reports : Furosemide Stress Test Use in Children at Risk for Acute K...
16/01/2026

📖 This weekend don't miss our Kidney International Reports : Furosemide Stress Test Use in Children at Risk for Acute Kidney Injury.
➡ http://lite.spr.ly/60093r9b
Grow professionally with the ISN. Access high-impact scientific and clinical research through our journals. Join/renew your ISN membership ➡️ http://lite.spr.ly/60013r9d
– Advancing kidney health worldwide. Together.

Kidney International® introduces a new article type, “Clinical Journey in Translational Medicine,” spotlighting patient ...
14/01/2026

Kidney International® introduces a new article type, “Clinical Journey in Translational Medicine,” spotlighting patient cases that link bedside observations to underlying mechanisms of disease.

“The patient’s journey is ultimately what it’s all about. “Clinical Journey in Translational Medicine” highlights how bedside insight and scientific discovery come together to advance kidney care.” KI Associate Editor, Jai Radhakrishnan

Submissions are open through the journal’s regular system. Learn more in the updated “Guide for Authors”: https://www.kidney-international.org/content/authorinfo -journey-in-translational-medicine-2-7

🔬 Stay on top of the evidence base shaping kidney careAt WCN’26, the High-Impact Trials and Late-Breaking Clinical Trial...
13/01/2026

🔬 Stay on top of the evidence base shaping kidney care

At WCN’26, the High-Impact Trials and Late-Breaking Clinical Trials sessions will bring you the studies that matter most for patient care, right now. From headline results to ongoing trials, these sessions are designed to help clinicians translate evidence into practice.

“As a community, this helps all of us stay on top of the evidence base needed to care for our patients,” says Adeera Levin, Chair of the ISN–Advancing Clinical Trials Committee and the WCN’26 LBCT Advisory Group. Read more: http://lite.spr.ly/6006Otc2

Expect:
✔️ Flagship late-breaking trials
✔️ Insights from ongoing studies like ASPIRE, RESOLVE, and VOICE
✔️ A focused IgA nephropathy session
✔️ Emerging therapies and innovative trial designs shaping the future of kidney research

📣 Tomorrow is the LAST DAY to register at the early bird rate! Don’t miss the chance to engage with the trials driving change in kidney care.

👉 Register now for WCN’26 before rates increase: http://lite.spr.ly/6008Otc4

🌍 The latest edition of INSIGHT is out!In this issue:✔️ Four new ISN Regional Training Centers in Malaysia, Philippines,...
13/01/2026

🌍 The latest edition of INSIGHT is out!
In this issue:
✔️ Four new ISN Regional Training Centers in Malaysia, Philippines, Thailand, and Fiji
✔️ Meet the new ISN Emerging Leaders
✔️ Read Adeera Levin's insights on 2026 HIT sessions
✔️ Discover new curriculum on the ISN Academy about genetics
… and much more!
➡️ http://lite.spr.ly/6003OtBd

Adres

Avenue Des Arts 1-2
Brussels
1210

Website

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer The International Society of Nephrology (ISN) nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Contact De Praktijk

Stuur een bericht naar The International Society of Nephrology (ISN):

Snelkoppelingen

Delen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

The International Society of Nephrology (ISN) is a philanthropic organization dedicated to advancing worldwide kidney health. We bridge the gaps of available care through advocacy and collaborations with our global partners. We build capacity with healthcare professionals via granting programs, education and research. By connecting communities, we develop a stronger understanding of how to manage kidney diseases and engage in a collaborative effort to improve prevention, diagnosis and treatment.

With over 10,000 professional members from over 150 countries, the ISN represents a wide international network and an efficient platform for timely scientific exchange, debate and communication between healthcare professionals involved in preventing and treating kidney disease. By collaborating with more than 100 national and regional societies, we reach out to an additional 30,000 health professionals globally.

Our overarching purpose is to tackle the global burden of acute kidney injury (AKI), chronic kidney disease (CKD) and end-stage kidney disease (ESKD), improving patient care through an interconnected advocacy, education and research strategy. www.theisn.org